Rare Gastroenterology News
Advertisement
Spotlight On
CAR-T therapy
Chimeric antigen receptor (CAR) T cell therapy is a type of cellular immunotherapy that changes T cells so they are able to recognize and attack cancer
5 Facts you should know
FACT
Chimeric antigen receptor (CAR) T-cell therapy is a technology that can genetically engineer immune cells T cells for use in immunotherapy
FACT
Chimeric antigen receptors are receptor proteins that have been engineered to give T cells the new ability to target a specific protein
FACT
The receptors are chimeric because they combine both antigen-binding and T cell activating functions into a single receptor
FACT
The CAR T-cell therapies approved by FDA to date target one of two antigens on B cells, CD19 or BCM
FACT
All currently available CAR T-cell therapies are allogeneic – and customized for each individual patient
Interest over time
Google searches